L3VLUP
ProSign in

DNLI · ARGX in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

DNLIARGX
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • DNLI
  • ARGX
0102030202120222023202420252026
Holders and value by quarter
QuarterDNLIARGX
Q3 20204 holders, $406m8 holders, $3.6bn
Q4 20207 holders, $1.6bn7 holders, $4.1bn
Q1 20217 holders, $1.2bn8 holders, $4.1bn
Q2 20215 holders, $1.7bn9 holders, $4.6bn
Q3 20216 holders, $1.1bn8 holders, $4.5bn
Q4 20214 holders, $709m9 holders, $5.3bn
Q1 20223 holders, $507m8 holders, $5.3bn
Q2 20225 holders, $481m13 holders, $6.5bn
Q3 20228 holders, $629m14 holders, $5.3bn
Q4 20226 holders, $766m13 holders, $5.5bn
Q1 20234 holders, $423m13 holders, $5.9bn
Q2 20236 holders, $760m18 holders, $6.6bn
Q3 20235 holders, $539m21 holders, $8.7bn
Q4 20238 holders, $577m17 holders, $6.3bn
Q1 20249 holders, $669m13 holders, $6.8bn
Q2 20249 holders, $829m14 holders, $7.9bn
Q3 20247 holders, $1.1bn13 holders, $10.7bn
Q4 20246 holders, $625m14 holders, $12.3bn
Q1 20255 holders, $422m17 holders, $11.8bn
Q2 20254 holders, $270m18 holders, $10.8bn
Q3 20255 holders, $333m16 holders, $13.8bn
Q4 20256 holders, $342m16 holders, $14.8bn
Q1 20267 holders, $372m11 holders, $12.3bn
Q2 20265 holders, $514m14 holders, $15.0bn
DNLI

Denali Therapeutics Inc

Holders
9
Reported value
$829m
Buyers
5
Sellers
3

Breadth +2 among 94 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP
ARGX

Argenx Se

Holders
14
Reported value
$7.9bn
Buyers
9
Sellers
7

Breadth +2 among 94 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP

Who holds both, Q2 2024

Among the 17 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only DNLI (3)

Baillie Gifford & Co, Capital Research Global Investors, PDT Partners LLC

Only ARGX (8)

Capital World Investors, Citadel Advisors LLC, ExodusPoint Capital Management LP, Fidelity (FMR LLC), Holocene Advisors LP, Janus Henderson Group Ltd, Moore Capital Management LP, T. Rowe Price Associates Inc

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →